2016 中国肾移植受者免疫抑制治疗指南(2016版)

2016-07-25 中华医学会器官移植学分会 器官移植.2016,7(5):1-5.

为提高临床医师对肾移植受者免疫抑制治疗的认识,规范国内肾移植受者管理,帮助医师在肾移植临床实践中做出合理决策,我们组织专家制订了《肾移植受者免疫抑制治疗指南(2016版)》。该指南以《2009版改善全球肾病预后组织(KDIGO)肾移植受者管理指南》为主要参考,结合我国的临床实践经验,希望能为相关临床科室提供工作指引。

中文标题:

2016 中国肾移植受者免疫抑制治疗指南(2016版)

发布日期:

2016-07-25

简要介绍:

为提高临床医师对肾移植受者免疫抑制治疗的认识,规范国内肾移植受者管理,帮助医师在肾移植临床实践中做出合理决策,我们组织专家制订了《肾移植受者免疫抑制治疗指南(2016版)》。该指南以《2009版改善全球肾病预后组织(KDIGO)肾移植受者管理指南》为主要参考,结合我国的临床实践经验,希望能为相关临床科室提供工作指引。


制定者: 
中华医学会器官移植学分会 
中国医师协会器官移植医师分会

下载附件:

(因为版权问题,不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=170384, encodeId=70681e03849a, content=太好了,对我帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a88c2009923, createdName=1e1e967fm80(暂无匿称), createdTime=Sat Jan 14 23:13:09 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105200, encodeId=9d16105200ae, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:19:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94915, encodeId=e3c894915b6, content=谢谢指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Thu Jul 28 06:07:00 CST 2016, time=2016-07-28, status=1, ipAttribution=)]
    2017-01-14 1e1e967fm80(暂无匿称)

    太好了,对我帮助很大

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=170384, encodeId=70681e03849a, content=太好了,对我帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a88c2009923, createdName=1e1e967fm80(暂无匿称), createdTime=Sat Jan 14 23:13:09 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105200, encodeId=9d16105200ae, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:19:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94915, encodeId=e3c894915b6, content=谢谢指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Thu Jul 28 06:07:00 CST 2016, time=2016-07-28, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用,特别实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=170384, encodeId=70681e03849a, content=太好了,对我帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a88c2009923, createdName=1e1e967fm80(暂无匿称), createdTime=Sat Jan 14 23:13:09 CST 2017, time=2017-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105200, encodeId=9d16105200ae, content=实用,特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:19:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=94915, encodeId=e3c894915b6, content=谢谢指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Thu Jul 28 06:07:00 CST 2016, time=2016-07-28, status=1, ipAttribution=)]
    2016-07-28 flysky120

    谢谢指南

    0